Learn more

PASTEUR INSTITUT KOREA

Overview
  • Total Patents
    96
  • GoodIP Patent Rank
    31,458
  • Filing trend
    ⇩ 85.0%
About

PASTEUR INSTITUT KOREA has a total of 96 patent applications. It decreased the IP activity by 85.0%. Its first patent ever was published in 2006. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are HUBEI BIO PHARMACEUTICAL IND TECHNOLOGICAL INST INC, PRESIDIO PHARMACEUTICALS INC and DAJITI FARMAS JUTIKAL KO LTD.

Patent filings per year

Chart showing PASTEUR INSTITUT KOREAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kang Sunhee 36
#2 Kim Jaeseung 35
#3 Lee Saeyeon 31
#4 Seo Min Jung 30
#5 Genovesio Auguste 30
#6 Christophe Thierry 21
#7 Ewann Fanny Anne 20
#8 Nam Ji Youn 20
#9 No Zaesung 20
#10 Emans Neil 19

Latest patents

Publication Filing date Title
WO2021075860A1 2-methoxyestradiol derivatives and medical uses thereof
KR20210009477A Anti-methicillin resistant staphylococcus aureus compound and its medical use
KR20200143972A Pharmaceutical composition for prevention or treatment of liver cancer or hepatocellular carcinoma
KR20190059864A Multicellular tumor spheroid for hepatocellular carcinoma therapy and drug screening method using the same
KR20190026179A SORD as a biomarker for prognosis of liver cancer
KR20190014370A Novel iminodipyridinopyrimidine analogs, its enantiomers, its diastereomers or its pharmaceutically acceptable salt and antiviral composition against hepatitis C virus containing the same as an active ingredient
KR20180036412A Novel compounds comprising carbohydrazide scaffold, its enantiomers, its diastereomers or its pharmaceutically acceptable salt and antiviral composition containing the same as an active ingredient
KR20180036415A Novel heteroaryl compounds, its enantiomers, its diastereomers or its pharmaceutically acceptable salt and antiviral composition containing the same as an active ingredient
KR20180036419A Novel compounds comprising thionicotinamide scaffold, its enantiomers, its diastereomers or its pharmaceutically acceptable salt and antiviral composition containing the same as an active ingredient
KR20180015943A Antiviral composition against hepatitis C virus comprising micrococcin P1 or analogue thereof
KR101723435B1 Novel human gene crucial for the replication of influenza virus and use thereof
KR101712856B1 Novel human gene crucial for the replication of influenza virus and use thereof
KR101693243B1 Novel human gene crucial for the replication of influenza virus and use thereof
KR101723434B1 Novel human gene crucial for the replication of influenza virus and use thereof
KR101788096B1 Kit and method for screening antibacterial compound using thiamine monophosphate kinase
KR101779038B1 Novel biomarker for predicting susceptibility of Staphylococcus aureus and uses thereof
CA2955565A1 2-amino-benzimidazole derivatives and their use as 5-lipoxygenase and/or prostaglandin e synthase inhibitors
EP3157904A1 Anti-infective compounds
KR20160141839A Compounds for treating viral infections
KR20170082450A Anti-infective compounds